Pharm: Derm Flashcards
bacitracin
- antibacterial agent
MOA: inhibits cell wall synthesis
tx: gram positive organism a - i.e. strep and staph, and some anaerobes
mupirocin
- antibacterial agent
MOA: inhibits protein synthesis
tx: gram positive bacteria including MRSA
** tx for impetigo caused by S. aureus and B-hemolytic strep
polymyxin B sulfate
- antibacterial agent
MOA: binds phsopholipids and increases permeability of cell wall
** a main ingredient in neosporin
tx: gram negative organisms
Neomycin
- antibacterial agent
MOA: binds 30s
tx: gram negative organisms
gentamicin
- antibacterial agent
MOA: binds 30s
tx: gram negative
Clindamycin
- antibacterial agent for acne
MOA: binds to 50s
Note: activitity against P. acnes
Erythromycin
- antibacterial agent for acne
MOA: binds 50s
Metronidazole
- antibacterial agent for acne
MOA: interacts with DNA causing srang breakage
tx: acne roscea
NOTE: CI during pregnancy
Acyclovir/penciclovir
topical antiviral
MOA: converted to pharmacologically active triphosphate metabolites, inhibit DNA synthesis and viral replication
Topical – modest benefit for herpes labialis
Also used systemically for HSV and VZV infections
docosanol
topical antiviral
MOA: inhibits fusion between the plasma membrane and the HSV envelope, thereby preventing viral entry and replication
When applied within 12 hours of the onset of prodromal symptoms, five times daily, median healing time was shortened by 18 hours compared with placebo in recurrent orolabial herpes
ciclopirox olamine
Topical antifungal
MOA: inhibits uptake of precursors of macromolecule synthesis
Uses: topical dermatomycosis, candidiasis, tinea versicolor, mild-to-moderate onychomycosis
Allylamine - terbinafine
Topical antifungal
MOA: inhibits squalene epoxidase
Uses: tinea corporis, tinea cruris, and tinea pedis
butenafine
Topical antifungal
MOA: inhibits squalene epoxidase
Uses: tinea corporis, tinea cruris, and tinea pedis
nystatin
Topical antifungal
MOA: binds ergosterol in fungal cell membrane altering permeability
Nystatin limited to topical cutaneous and mucosal uses = Thrush
amphotericin B
Topical antifungal
MOA: binds ergosterol in fungal cell membrane altering permeability
Amphotericin B broad antifungal spectrum but rarely used topically
= Cumulative organ toxicity (ampho-terrible)
imiquimod
imunomodulator
MOA: may be related to stimulation of peripheral mononuclear cells to release interferon-α and macrophage stimulation to produce interleukins-1, -6, -8, and TNF-α
Uses: external genital and perianal warts in adults, actinic keratoses on the face and scalp, biopsy-proven primary basal cell carcinomas on the trunk, neck, and extremities (< 2 cm diameter)
ADRs: local inflammation, pruritus, erythema, superficial erosion
tacrolimus/pimecrolimus
imunomodulator
MOA: inhibit T-lymphocyte activation and prevent release of inflammatory cytokines and mediators from mast cells
Uses: treatment of atopic dermatitis and psoriasis
**traditionally used to prevent heart, liver, and kidney allograft rejection due to potent immunosuppressive activity (oral forms)
Topical ADRs: transient erythema, burning, and pruritus
retinoic acid, tretinoin
topical acne prep
= acid form of Vitamin A
MOA: may decrease cohesion b/w epidermal cells and increase cell turnover
AE: erythema, mild peeling, dryness, increased photosensitivity
adapalene
acne: topical retinoic acid derivative
MOA: may decrease cohesion b/w epidermal cells and increase cell turnover
- photochemically more stable and less irritating than tretinoin
used to tx mild-moderate acne vulgaris
tazarotene
acne: topical retinoic acid derivative
MOA: may decrease cohesion b/w epidermal cells and increase cell turnover
approved for psoriasis, acne and photoaging
NOTE: CI for pregnant women!